News
Eli Roth‘s The Horror Section has acquired “Jimmy and Stiggs,” marking the horror company’s first major deal since launching earlier this month, Variety can exclusively report. Directed ...
Jesse, Judy, and Kelvin see the vacation as the picture-perfect opportunity to wreck their father Eli’s romance blooming with Lori. Nevertheless, their complex schemes don’t go as planned, with The ...
Reserve your spot now. Eli Lilly And Co LLY, on Sunday, announced positive Phase 2 results for lepodisiran, an investigational small interfering RNA (siRNA) therapy designed to lower the ...
There’s a common misconception outside of the Jello Belt that all Latter-day Saints are roughly the same. That, as a whole, the religion is packed with a mass of homogenous doe-eyed Osmonds who ...
Global pharmaceutical giant Eli Lilly is expanding its footprint in India with a new technology center in Hyderabad as part of its broader strategy to enhance global research and development ...
Eli Lilly’s global CEO David Ricks has highlighted the significant costs of bringing new drugs to market, revealing that the average cost of developing a single drug is around $4 billion—even before ...
Mumbai | New Delhi: Pharma major Eli Lilly is open to partnerships with Indian companies to sell its blockbuster anti-diabetes and weight loss drug Mounjaro (tirzepatide), global CEO David Ricks told ...
Promise. From TikTok star and the author of I Didn’t Know I Needed This Eli Rallo, a reflection on the anxiety of transitioning into adulthood, navigating the quarter-life crisis, and realizing ...
Mounjaro: As Eli Lilly's blockbuster anti-obesity drug comes to India, expert lists key side effects
Eli Lilly has launched Mounjaro, a first-of-its-kind drug for obesity and type 2 diabetes, in India. This medication, approved by CDSCO, helps with weight management and activates hormone receptors.
The new class of weight-loss medicines that has taken the world by a storm will now become available in India, with the pharmaceutical giant Eli Lilly on Thursday announcing the launch of tirzepatide ...
Eli Lilly and Company launched its weight loss drug Mounjaro in India on Thursday after obtaining approval from the Central Drugs Standard Control Organisation (CDSCO). This is a drug which ...
“Semaglutide generics will be priced almost 95% lower than [Eli Lilly'] current price,” said Vishal Manchanda, senior vice-president, institutional research at Systematix Group. With the drop ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results